Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
3.030
+0.120 (4.12%)
At close: Aug 13, 2025, 4:00 PM
3.030
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:33 AM EDT
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $826.37 million as of August 14, 2025. Its market cap has increased by 78.42% in one year.
Market Cap
826.37M
Enterprise Value
571.47M
1-Year Change
78.42%
Ranking
Category
Stock Price
$3.03
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has increased from $690.43M to $826.37M, an increase of 19.69%. That is a compound annual growth rate of 3.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 624.67M | 76.18% |
| Dec 31, 2024 | 354.55M | 7.14% |
| Dec 29, 2023 | 330.92M | 134.50% |
| Dec 30, 2022 | 141.12M | -68.52% |
| Dec 31, 2021 | 448.22M | -55.28% |
| Dec 31, 2020 | 1.00B | 45.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |